FDA Inspection
IntelliPharmaCeutics Corp.IntelliPharmaCeutics Corp. – FDA Inspection, Jun 14, 2019
Record Details
This FDA Inspection record concerns IntelliPharmaCeutics Corp., with an inspection on June 14, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c33b77c0-b3fa-45f7-ae87-48a3ec032d64
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1095607
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of IntelliPharmaCeutics Corp.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| September 26, 2022 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 14, 2017 | Not classified | Office of Inspections and Investigations | |
| May 24, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 23, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 18, 2010 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for IntelliPharmaCeutics Corp.
- FDA Inspection 1190656 - 2022-09-26
- FDA Inspection 1027099 - 2017-07-14
- FDA Inspection 885403 - 2014-05-24
- FDA Inspection 737274 - 2011-07-23
- FDA Inspection 698518 - 2010-11-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.